Beryl Drugs Limited (BOM:524606)
20.29
-0.83 (-3.93%)
At close: Apr 30, 2025
Beryl Drugs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Cash & Equivalents | - | 1.25 | 2.83 | 2.71 | 4.52 | 3.96 | Upgrade
|
Short-Term Investments | - | 0.98 | 2.91 | 4 | 2.02 | 1.87 | Upgrade
|
Cash & Short-Term Investments | 1.78 | 2.23 | 5.74 | 6.72 | 6.54 | 5.84 | Upgrade
|
Cash Growth | -59.81% | -61.13% | -14.55% | 2.64% | 12.12% | 217.02% | Upgrade
|
Accounts Receivable | - | 75.84 | 69 | 44.49 | 45.41 | 34.54 | Upgrade
|
Other Receivables | - | 0.13 | 4.28 | 16.2 | 17.72 | 17.63 | Upgrade
|
Receivables | - | 75.97 | 73.43 | 60.69 | 63.13 | 52.17 | Upgrade
|
Inventory | - | 16.65 | 11.25 | 29.78 | 22.69 | 11.57 | Upgrade
|
Prepaid Expenses | - | 0.27 | 0.13 | 0.33 | 0.03 | 0.21 | Upgrade
|
Other Current Assets | - | 7.09 | 13.34 | 7.8 | 9.14 | 5.35 | Upgrade
|
Total Current Assets | - | 102.22 | 103.89 | 105.32 | 101.52 | 75.14 | Upgrade
|
Property, Plant & Equipment | - | 59.61 | 58.1 | 58.6 | 73.24 | 83.33 | Upgrade
|
Long-Term Investments | - | - | 1.53 | 1.64 | 1.2 | 5.62 | Upgrade
|
Other Intangible Assets | - | 0.01 | 0.01 | 0.02 | 0.04 | 0.07 | Upgrade
|
Long-Term Deferred Tax Assets | - | 1.03 | 1.26 | 1.86 | - | - | Upgrade
|
Other Long-Term Assets | - | 12 | 10.32 | 10.79 | 10.48 | 4.96 | Upgrade
|
Total Assets | - | 174.87 | 175.11 | 178.24 | 186.48 | 169.12 | Upgrade
|
Accounts Payable | - | 20.16 | 32.48 | 30.57 | 22.2 | 18.02 | Upgrade
|
Accrued Expenses | - | 2.4 | 1.91 | 1.73 | 10.1 | 10.14 | Upgrade
|
Short-Term Debt | - | 23.85 | 15.88 | 33.72 | 23.54 | 23.93 | Upgrade
|
Current Portion of Long-Term Debt | - | 3.05 | 2.48 | 2.47 | 7.84 | 5.3 | Upgrade
|
Current Income Taxes Payable | - | 1.1 | 0.66 | - | 0.54 | 0.28 | Upgrade
|
Other Current Liabilities | - | 7 | 10.02 | 16.44 | 17.92 | 8.61 | Upgrade
|
Total Current Liabilities | - | 57.55 | 63.42 | 84.92 | 82.13 | 66.28 | Upgrade
|
Long-Term Debt | - | 24.04 | 27.06 | 16.75 | 19.86 | 23.12 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | - | 2.05 | 0.81 | Upgrade
|
Total Liabilities | - | 85.64 | 94.45 | 105.3 | 107.19 | 92.86 | Upgrade
|
Common Stock | - | 50.72 | 50.72 | 50.72 | 50.72 | 50.72 | Upgrade
|
Retained Earnings | - | 37.68 | 29.99 | 22.33 | 28.92 | 26.53 | Upgrade
|
Comprehensive Income & Other | - | 0.84 | -0.05 | -0.11 | -0.34 | -0.99 | Upgrade
|
Shareholders' Equity | 93.03 | 89.23 | 80.66 | 72.94 | 79.29 | 76.25 | Upgrade
|
Total Liabilities & Equity | - | 174.87 | 175.11 | 178.24 | 186.48 | 169.12 | Upgrade
|
Total Debt | 45.31 | 50.94 | 45.42 | 52.94 | 51.24 | 52.35 | Upgrade
|
Net Cash (Debt) | -43.54 | -48.71 | -39.68 | -46.22 | -44.69 | -46.51 | Upgrade
|
Net Cash Per Share | -8.57 | -9.60 | -7.82 | -9.11 | -8.81 | -9.17 | Upgrade
|
Filing Date Shares Outstanding | 5.08 | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 | Upgrade
|
Total Common Shares Outstanding | 5.08 | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 | Upgrade
|
Working Capital | - | 44.66 | 40.47 | 20.4 | 19.39 | 8.86 | Upgrade
|
Book Value Per Share | 18.37 | 17.59 | 15.90 | 14.38 | 15.63 | 15.04 | Upgrade
|
Tangible Book Value | 93.02 | 89.22 | 80.65 | 72.91 | 79.26 | 76.18 | Upgrade
|
Tangible Book Value Per Share | 18.37 | 17.59 | 15.90 | 14.38 | 15.63 | 15.02 | Upgrade
|
Land | - | 2.55 | 2.55 | 2.55 | 2.55 | 2.55 | Upgrade
|
Buildings | - | 23.92 | 20.47 | 21.12 | 21.57 | 20.52 | Upgrade
|
Machinery | - | 88.81 | 80.21 | 72.05 | 76.01 | 74.64 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.